Injection Drug Use Surveillance Project

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Injection Drug Use Surveillance Project	Form and Instruction	New	Repair queued
Att 12 Sample Analysis Tables.docx	Supplementary Document	Uploaded 2020-07-06	Repair queued
Privacy Act Checklist.docx	Supplementary Document	Uploaded 2020-07-06	Repair queued
Att 9 Assurance of Confidentiality.docx	Supplementary Document	Uploaded 2020-07-06	Repair queued
Att 8 Recruitment Coupon spreadsheet.xlsx	Supplementary Document	Uploaded 2020-07-06	Missing upstream
Att 4 Model Recruitment Coupon.pdf	Supplementary Document	Uploaded 2020-07-06	Repair queued
Att 2a - Public Comment.docx	Supplementary Document	Uploaded 2020-07-06	Repair queued
Att 1 Authorizing Legislation.docx	Supplementary Document	Uploaded 2020-07-06	Available
Supporting Statement B.docx	Supporting Statement B	Uploaded 2020-06-22	Repair queued
Supporting Statement A.docx	Supporting Statement A	Uploaded 2020-06-22	Repair queued

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
242583	Injection Drug Use Surveillance Project	Form and Instruction	New

ICR Details

OMB Control No:	ICR Reference No: 202006-0920-011
Status: Received in OIRA	Previous ICR Reference No:
Agency/Subagency: HHS/CDC	Agency Tracking No:
Title: Injection Drug Use Surveillance Project
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 07/21/2020

table that charts list comparision

	Requested	Previously Approved
Expiration Date	36 Months From Approved
Responses	28,499	0
Time Burden (Hours)	6,125	0
Cost Burden (Dollars)	0	0

---

Abstract: The main goals of the Injection Drug Use (IDU) surveillance project are to assess the following among 6-30 syringe service programs (SSPs) in the US: 1) the risk behaviors, injection risk networks, receipt of prevention services, and barriers to prevention and care among persons who inject drugs (PWID) and their drug-using (i.e. either injecting or non-injecting) peers; and 2) the prevalence of HIV and Hepatitis C (HCV infections) among PWID and their drug-using peers.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 13655	03/09/2020
30-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 43838	07/20/2020
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
Injection Drug Use Surveillance Project	N/A, N/A, N/A	Project Permission Form ,   IDU Survey ,   Eligibility screening form

---

ICR Summary of Burden

table that charts list of burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	28,499	0	0	28,499	0	0
Annual Time Burden (Hours)	6,125	0	0	6,125	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: This is a new collection requesting approval for 6,125 hours.

---

Annual Cost to Federal Government: $3,147,032

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 07/21/2020

---